BATM Advanced Communications (BVC) AI Stock Analysis

• Market Cap: £70.85M
• Dividend Yield: N/A
• Average Volume (3M): 394.03K
• Price to Earnings (P/E): ―
• Beta (1Y): -0.05
• Revenue Growth: -6.71%
• EPS Growth: -8020.00%
• Country: UK
• Employees: 867
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Instruments & Supplies
• EPS (TTM): <0.01
• Shares Outstanding: 436,681,670
• 10 Day Avg. Volume: 566,247
• 30 Day Avg. Volume: 394,026
• PEG Ratio: N/A
• Price to Book (P/B): 0.00
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: £16.50
• Price Target Upside: 1.73% Upside
• Rating Consensus: Hold
• Number of Analyst Covering: 0

• Rating: 53 Neutral
• Price Target: 16.50p ▲(1.73% Upside)

The overall stock score is primarily influenced by financial performance challenges, including declining revenues and profitability issues. Technical analysis provides a neutral outlook with some bullish momentum, while valuation concerns due to negative earnings further weigh down the score.

BATM Advanced Communications Business Overview & Revenue Model

Company Description

BATM Advanced Communications Ltd., together with its subsidiaries, provides real-time technologies for networking solutions and bio-medical systems in Israel, the United States, and Europe. It operates in Networking and Cyber, and Bio-Medical divisions. The Networking and Cyber division is involved in the research and development, production, and marketing of data communication products, including network function virtualization, carrier ethernet and MPLS access solutions, and cyber network monitoring. It also offers software services, such as training and technical support, laboratory service and maintenance; and construction contracts. The Bio-Medical division engages in the research and development, production, marketing, and distribution of medical products, such as laboratory diagnostics and sterilization equipment. This division offers molecular biology diagnostics; provides solutions to treat pathogenic and medical waste in laboratories and hospitals, as well as for pharmaceutical manufacturing plants and agricultural applications; and distributes diagnostic equipment and medical supplies of various brands. BATM Advanced Communications Ltd. has a collaboration with Novamed Ltd for the joint development and marketing of a home-use testing kit for COVID-19. The company was founded in 1992 and is headquartered in Hod Hasharon, Israel.

How the Company Makes Money

BATM Advanced Communications generates revenue through multiple streams, primarily from the sale of its telecommunications equipment and software solutions. The company earns money by providing advanced network infrastructure to telecommunications operators and enterprises, which includes hardware and software products. Additionally, BATM offers maintenance and support services for its products, contributing to ongoing revenue. Significant partnerships with telecom operators and technology providers enhance its market presence and facilitate large-scale projects, which also serve as critical revenue sources. The company's focus on research and development allows it to innovate continuously, keeping it competitive in the fast-evolving tech landscape and attracting new clients.

BATM Advanced Communications Financial Statement Overview

Summary

BATM Advanced Communications is facing financial challenges, with declining revenues and profitability issues reflected in negative margins and cash flow deficits. Although the balance sheet is relatively stable with manageable debt levels, the company needs to address its operational inefficiencies to improve its financial health.

Income Statement

BATM Advanced Communications experienced a significant decline in revenue from 2020. The gross profit margin has been decreasing, with a negative net profit margin in recent years, indicating profitability challenges. The company showed negative EBIT and EBITDA margins for the latest year, reflecting operational inefficiencies.

Balance Sheet

The company maintains a low debt-to-equity ratio, suggesting prudent leverage management. However, the equity ratio has declined, indicating a decrease in equity relative to total assets. ROE has turned negative recently due to net losses, but the company still holds a strong cash position relative to its debt obligations.

Cash Flow

Free cash flow has been negative recently, showing a concerning trend of cash outflow exceeding inflow. The operating cash flow to net income ratio turned negative, reflecting cash flow challenges even as the company faces net losses. However, the company previously demonstrated the ability to generate positive cash flows.

Breakdown	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	117.34M	122.83M	116.12M	140.04M	183.57M
Gross Profit	36.80M	39.89M	37.96M	51.06M	60.71M
EBITDA	972.00K	8.01M	8.12M	31.06M	19.84M
Net Income	-22.30M	-193.00K	1.56M	14.34M	9.79M
Balance Sheet
Total Assets	149.16M	174.63M	175.18M	193.16M	200.11M
Cash, Cash Equivalents and Short-Term Investments	31.57M	40.76M	44.17M	67.76M	53.38M
Total Debt	8.65M	9.08M	9.98M	10.28M	16.72M
Total Liabilities	56.18M	55.19M	61.18M	69.03M	81.34M
Stockholders Equity	94.06M	120.34M	115.07M	127.42M	122.59M
Cash Flow
Free Cash Flow	-5.06M	-177.00K	-7.25M	2.30M	14.74M
Operating Cash Flow	-1.65M	5.01M	-2.78M	5.59M	18.46M
Investing Cash Flow	-1.22M	-6.12M	-16.34M	15.07M	-5.48M
Financing Cash Flow	-2.61M	-2.16M	-7.05M	-4.94M	-3.25M

BATM Advanced Communications Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 16.22
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:BVC, the sentiment is Negative. The current price of 16.22 is below the 20-day moving average (MA) of 16.23, above the 50-day MA of 15.96, and below the 200-day MA of 16.38, indicating a neutral trend. The MACD of 0.21 indicates Negative momentum. The RSI at 50.01 is Neutral, neither overbought nor oversold. The STOCH value of 52.04 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for GB:BVC.

BATM Advanced Communications Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
TSTL	74 Outperform	176.58M	28.66	―	3.77%	10.32%	1.25%
GAMA	70 Outperform	893.95M	13.79	18.74%	2.10%	11.95%	20.69%
CTEC	66 Neutral	4.53B	27.50	11.28%	2.24%	4.18%	37.65%
AMS	64 Neutral	468.35M	51.06	2.95%	1.24%	68.03%	-18.27%
BVC	53 Neutral	£70.85M	―	-6.46%	―	-6.71%	-8020.00%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%

BATM Advanced Communications Corporate Events

BATM Advanced Communications Reports Strong Interim Results and Strategic Progress

BATM Advanced Communications reported strong interim results for the first half of 2025, with revenue growth and improved gross margins across its core divisions. The company achieved significant milestones, including the launch of new products in its network division and the delivery of its first commercial encryption platform. Strategic actions, such as the sale of non-core businesses and a new brand identity, have positioned BATM for continued growth and focus on its core strengths in networks, cybersecurity, and diagnostics.

BATM Advanced Communications Announces Total Voting Rights

BATM Advanced Communications announced its total voting rights, stating that the group’s issued share capital consists of 441,176,669 ordinary shares, with 4,495,000 held in treasury. Shareholders should use the figure of 436,681,669 as the denominator for calculating their interest in the company’s share capital, as per the FCA’s rules.

BATM Advanced Communications Sells Non-Core Businesses to Focus on Core Operations

BATM Advanced Communications has announced the sale of three non-core businesses, including Celitron and Zer Laboratories, as part of its strategic focus on core operations in networks, cyber, and diagnostics. This move is expected to reduce costs and commitments, with the company receiving a total of approximately $383,000 from these disposals. Additionally, the sale of its Progenetics subsidiary was completed for $2 million. BATM will release its interim results for the first half of 2025 on August 18, 2025, as it continues to pursue further disposals and M&A opportunities to accelerate growth in its core divisions.

BATM Advanced Communications Sells Non-Core Businesses to Focus on Core Operations

BATM Advanced Communications has announced the sale of three non-core businesses, including Celitron and Zer Laboratories, as part of its strategic focus on core operations in networks, cyber, and diagnostics. This move is expected to reduce costs and commitments, with the sales generating approximately $383k and $2m in cash considerations. The company plans to continue pursuing further disposals and M&A opportunities to accelerate growth in its core divisions.

BATM Announces CFO Transition Amidst Continued Growth

BATM Advanced Communications has announced a leadership change with the resignation of Ran Noy as CFO and the appointment of Leor Miles, CPA, as his successor. Lior, who previously served as VP Finance at BATM, brings extensive experience from his role at Kenes Group. The transition is expected to be smooth, with no material impact on the company’s operations or its strategic direction, despite geopolitical tensions in the Middle East.